---
title: "Beyond Concentration: The New Era of Advanced Hyaluronic Acid Delivery Systems"
description: Our focus today returns to a staple in skincare—Hyaluronic Acid (HA)—but introduces a revolutionary new application that is changing cosmetic chemistry. While the industry is familiar with the different molecular
url: https://www.dmcostech.com/blog/beyond-concentration-the-new-era-of-advanced-hyaluronic-acid-delivery-systems
markdown_url: https://www.dmcostech.com/blog/beyond-concentration-the-new-era-of-advanced-hyaluronic-acid-delivery-systems.md
type: post
slug: beyond-concentration-the-new-era-of-advanced-hyaluronic-acid-delivery-systems
author: dmcostech
published: 2026-07-03T10:22:43Z
modified: 2026-07-03T10:22:46Z
language: en-US
taxonomies:
  category:
    - Ingredients Introduction
word_count: 700
tokens: 1384
---

# Beyond Concentration: The New Era of Advanced Hyaluronic Acid Delivery Systems

Our focus today returns to a staple in skincare—Hyaluronic Acid (HA)—but introduces a revolutionary new application that is changing cosmetic chemistry.

While the industry is familiar with the different molecular weights, structures, and benefits of HA, the frontier of skincare science has advanced. Introducing the&nbsp;VectorHyal™ Microencapsulation Delivery Platform&nbsp;by Givaudan.

This platform transforms HA from a standalone active ingredient into a highly functional &#8220;shell material.&#8221; It serves as a vital structural carrier in microencapsulation technology, effectively housing high concentrations of sensitive active ingredients to ensure efficient transdermal penetration and uniform dermal distribution.

High Molecular Weight (HMW) Hyaluronic Acid: A Breakthrough Structural Evolution

Traditionally, High Molecular Weight (HMW) Hyaluronic Acid functions by forming a moisture-locking film on the skin&#8217;s surface. Givaudan&#8217;s innovation shifts the focus to HA&#8217;s structural properties. The exceptional viscoelasticity of HMW HA creates a robust physical network—the mechanical foundation required to stably encapsulate active ingredients and ensure a dense, resilient microcapsule shell.

By precisely incorporating macromolecular polysaccharides (such as sodium alginate) and calcium chloride, ordered aggregates are formed through electrostatic interactions between the positive and negative charges of the macromolecular chains. This meticulous process creates highly stable supramolecular microcapsules. Under electron microscopy, these VectorHyal™ microcapsules demonstrate an optimal particle size of 350-400nm.

The HMW HA Shell: Dense Encapsulation with Enzymatic Slow-Release

Once the microcapsules carrying active ingredients penetrate the skin, they interact with naturally occurring hyaluronidase (the skin&#8217;s native HA-degrading enzymes). This enzyme specifically targets and degrades the HMW HA shell, facilitating a controlled, slow release of the active compounds deep into the dermal layers.

The Clinical Advantages of VectorHyal™ Microencapsulation Technology

Understanding this technological shift highlights the distinct, clinically backed advantages of Givaudan’s delivery system:

1. 100% Natural Origin
Formulated with sustainability in mind, the HMW HA is sourced via a circular biorefinery system and manufactured using a solvent-free, solar-powered process, ensuring a 100% natural and eco-friendly profile.

2. Broad Compatibility &amp; Formulation Clarity
This platform supports the encapsulation of both lipophilic (oil-soluble) and hydrophilic (water-soluble) substances, boasting an impressive active ingredient loading capacity of up to 20%. It is highly protective for temperature- and oxygen-sensitive compounds. Notably, when encapsulating hydrophilic actives, the final cosmetic formulation remains completely transparent—ideal for elegant serum formulations.

3. Clinically Proven Enhancements in Penetration Depth and Distribution

Deeper, Superior Penetration: To validate the penetration-enhancing efficacy of VectorHyal™, ex vivo studies were conducted on human skin explants (from a 56-year-old donor). A topical treatment was applied for 8 hours, utilizing Raman spectroscopy to detect HA signals. The study compared VectorHyal™ (encapsulating 20% medium molecular weight HA) against untreated controls, empty VectorHyal™ bases, and free HA solutions. The results demonstrated that VectorHyal™ encapsulation significantly boosted penetration to depths of up to 70 μm. Semi-quantitative analysis revealed that VectorHyal™ delivers a penetration efficacy 7 times higher than that of free HA.

Uniform Intra-Dermal Distribution: Using advanced 3D skin clearing technology and Rhodamine as a fluorescent marker, the dermal distribution was tracked. While unencapsulated Rhodamine remained entirely trapped on the stratum corneum with zero penetration, the encapsulated actives successfully penetrated the skin and exhibited highly uniform distribution throughout the epidermis.

4. Dual-Action HA Shell: Intrinsic Skincare Efficacy
Beyond acting as a superior delivery vehicle, the HMW HA shell retains its native biological benefits, providing clinically proven supplementary hydration and anti-wrinkle effects:

Immediate Hydration Efficacy (Corneometer® Analysis): Following a single application, the VectorHyal™ group increased skin hydration by 13.2% after 1 hour and 14.1% after 6 hours compared to a placebo. When compared to the same encapsulation technology formulated without HA, hydration improved by 14.2% (1h) and 14.9% (6h), marking a highly significant enhancement in skin moisture levels.

Intensive Moisture Retention (Easystiff® Biomechanical Analysis): Six hours post-application, the stiffness of both the stratum corneum and the epidermis decreased significantly. This indicates profound epidermal hydration, vastly outperforming both the placebo and the non-HA encapsulation control groups.

Comprehensive Anti-Aging: Clinically shown to visibly reduce fine lines, improve deep wrinkles, and smooth overall skin texture within just 7 days.

Unlock the Future of Skincare Formulations

With an intrinsically active HA shell and a skin-specific, enzyme-triggered slow-release mechanism, this advanced delivery system can be exclusively customized for your brand&#8217;s unique formulations.

Contact DMCOS today to learn more and unlock revolutionary possibilities for active ingredient encapsulation in your product line!
